Direct naar content
IBSFM English
Private equity

IBS Private Equity Growth Fund

This fund invests in three funds and will make direct investments in part with the fund managers.

EUR 65 million
Commitment
10 years
Duration

The IBS Private Equity Growth Fund is investing 75% of the committed capital in Permira Growth Opportunities Fund II, Keensight Capital Fund VI and Quadriga Capital Fund VI. We will invest the remaining 25% in direct co-investments with these three managers.

The fund pursues a “middle market growth” strategy. This strategy focuses on companies in a relatively opaque market, with lower valuation multiples, lower debt levels and high growth potential.

Furthermore, the fund specifically focuses on sectors that are in a growth phase, partly due to technological or demographic developments. These include technology, healthcare, automation, B2B services, e-commerce and fintech.

Funds characteristics

  • Fund name
    IBS Private Equity Growth Fund
  • Investingstrategy
    Private Equity – Middle Market Growth
  • Geography
    Europe & North America
  • Vintage and duration
    2021 – 2031
  • Fund managers
    Permira Growth Opportunities II, Keensight Capital Nova VI, Quadriga Capital VI
  • IBS Commitment
    EUR 65 mln, gemiddeld EUR 16,25 per fonds
  • Status
    Closed for investors
  • Minimal investment
    EUR 250.000,-
  • Fund type
    Common account fund (CIS).

Structure

  • Fund of Funds
    IBS Private Equity Growth Fund FGR
  • Master Funds
    Permira Growth Opportunities II, Keensight Nova VI, Quadriga Capital VI
  • Administrator Fund of Funds
    IBS Fund Management B.V
  • Custodian
    CACEIS KAS Trust & Depositary Services BV

Want to know more about this fund?

The prospectuses of the closed-end investment institutions managed for IBS Fund Management B.V. and those of the underlying master investment institutions are available to unitholders upon request (in the secure area of the site and at info@ibsfm.nl).